{"id":1866,"date":"2026-09-26T14:35:34","date_gmt":"2026-09-26T18:35:34","guid":{"rendered":"https:\/\/simplelifescience.com\/?page_id=1866"},"modified":"2026-10-10T20:48:17","modified_gmt":"2026-10-11T00:48:17","slug":"retatrutide-cagrilintide-research-blend-overview","status":"publish","type":"page","link":"https:\/\/simplelifescience.com\/es\/retatrutide-cagrilintide-research-blend-overview\/","title":{"rendered":"Retatrutide \/ Cagrilintide Research Peptide Blend | Simple Life Science"},"content":{"rendered":"\n
\n

The retatrutide \/ cagrilintide research blend is a defined two-component lyophilized research material combining retatrutide, a peptide studied as a glucagon, GLP-1 and GIP receptor agonist, with cagrilintide, an amylin analog, for controlled laboratory investigation.<\/strong> Simple Life Science supplies it (catalog shorthand SP-3RT\/Cag) for laboratory research use only, with batch-specific COA documentation. Guest checkout is open: no account is needed to order.<\/p>\n

For research use only. Not for human or veterinary use. Not for consumption. No dosing, administration or medical guidance is provided.<\/em><\/p>\n\n

Blend specifications<\/h2>\n\n\n
Components<\/th>Retatrutide + cagrilintide<\/td><\/tr>\n
Catalog number<\/th>GRCG-PW (GRCG-PW-12.5MG-2.5MG, GRCG-PW-25MG-5MG)<\/td><\/tr>\n
Pack options<\/th>12.5 mg \/ 2.5 mg and 25 mg \/ 5 mg (retatrutide \/ cagrilintide, per catalog SKU)<\/td><\/tr>\n
Format<\/th>Lyophilized, multi-component research material<\/td><\/tr>\n
Purity specification<\/th>Finished-material release specification of at least 99% unless a molecule-specific specification applies; the lot COA controls<\/td><\/tr>\n
Storage<\/th>Follow the product label and lot documentation<\/td><\/tr>\n
Documentation<\/th>Batch-specific Certificate of Analysis from Freedom Diagnostics Testing<\/td><\/tr>\n<\/tbody>\n<\/table>\n\n

Sample lot COAs<\/h2>\n

From our public Documentation Library<\/a> (search “Cagrilintide” to see every lot):<\/p>\n